Cutera (CUTR – Research Report) received a Hold rating and price target from Maxim Group analyst Anthony Vendetti yesterday. The company’s shares closed yesterday at $2.18.
According to TipRanks, Vendetti is an analyst with an average return of -6.1% and a 32.19% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Nuwellis, Lucid Diagnostics, and Myomo.
In addition to Maxim Group, Cutera also received a Hold from Piper Sandler’s Matthew O’Brien in a report issued yesterday. However, on April 29, Stifel Nicolaus maintained a Buy rating on Cutera (NASDAQ: CUTR).
CUTR market cap is currently $43.41M and has a P/E ratio of -0.30.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cutera (CUTR) Company Description:
Cutera, Inc. provides laser and energy-based aesthetic systems for practitioners, which engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. Its products include Enlighten, TruSculpt, Excel HR, Excel V, and Xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
